Advertisement

Classical Framework for Case-Driven Design of Advanced Targeted Nanomedical Solution

  • Uche Chude-Okonkwo
  • Reza MalekianEmail author
  • B. T. Maharaj
Chapter
Part of the Nanomedicine and Nanotoxicology book series (NANOMED)

Abstract

The development and deployment of ATN solutions require relentless interdisciplinary efforts in order to bring the system and its tremendous promises to reality. The level of the interdisciplinary commitment can encompass diverse fields such as nanotechnology, communication engineering, electronics, medical biology, systems biology, computational biology, synthetic biology, genetic engineering, molecular engineering, molecular/supramolecular chemistry, atomic/molecular physics, biophysics, bioelectronics, signal processing, information theory, advanced mathematics and translational science (Farokhzad and Langer in Adv Drug Deliv Rev 58:1456–1459, 2006, [1]). With this knowledge spread and planning, the design and development/fabrication of an ATN solution for a particular health challenge can be effectively achieved. It is therefore necessary to develop a framework that will serve as a guide for researchers through the design process and the steps in achieving the ATN goal. This exercise will eventually translate the ATN from the paper-based fundamental research, through the experimental stage to clinical reality.

References

  1. 1.
    Farokhzad OC, Langer R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58:1456–1459CrossRefGoogle Scholar
  2. 2.
    Chude-Okonkwo UAK, Malekian R, Maharaj BT (2016) Molecular communication model for targeted drug delivery in multiple disease sites with diversely expressed enzymes. IEEE Trans Nanobiosci 15(3):230–245CrossRefGoogle Scholar
  3. 3.
    Alexis F, Pridgenm E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515CrossRefGoogle Scholar
  4. 4.
    Kowalczyk SW, Blosser TR, Dekker C (2011) Biomimetic nanopores: learning from and about nature. Trends Biotechnol 29:607–614CrossRefGoogle Scholar
  5. 5.
    Adiga SP, Jin C, Curtiss LA, Monteiro-Riviere NA, Narayan RJ (2009) Nanoporous membranes for medical and biological applications. Wiley Interdisc Rev Nanomed Nanobiotechnol 1:568–581CrossRefGoogle Scholar
  6. 6.
    Cormode DP, Naha PC, Fayad ZA (2014) Nanoparticle contrast agents for computed tomography: a focus on micelles. Contrast Media Mol Imaging 9:37–52CrossRefGoogle Scholar
  7. 7.
    Anderson CE et al (2017) Dual contrast-magnetic resonance fingerprinting (DC-MRF): a platform for simultaneous quantification of multiple MRI contrast agents. Sci Rep 7(8431)Google Scholar
  8. 8.
    Han HS et al (2015) Quantum dot/antibody conjugates for in vivo cytometric imaging in mice. Proc Natl Acad Sci 112:1350–1355CrossRefGoogle Scholar
  9. 9.
    Chude-Okonkwo UAK, Malekian R, Maharaj BT, Vasilakos AV (2017) Molecular communication and nanonetwork for targeted drug delivery: a survey. IEEE Commun Surv Tutorials 19:3046–3096CrossRefGoogle Scholar
  10. 10.
    Ingalls B (2013) Mathematical modelling in systems biology: an introduction. MIT PressGoogle Scholar
  11. 11.
    Chude-Okonkwo UAK, Malekian R, Maharaj BT (2015) Diffusion-controlled interface kinetics-inclusive system-theoretic propagation models for molecular communication systems. EURASIP J Adv Signal Process 89:1–23Google Scholar
  12. 12.
    Chude-Okonkwo UAK (2014) Diffusion-controlled enzyme-catalyzed molecular communication system for targeted drug delivery. In: 2014 IEEE global communications conference, Austin, Texas, pp 2826–2831Google Scholar
  13. 13.
    Wolfram S (1984) Cellular automata as models of complexity. Nature 311:419–424CrossRefGoogle Scholar
  14. 14.
    Ditlevsen S, Samson A (2013) Introduction to stochastic models in biology. In: Bachar M, Batzel JJ, Ditlevsen S (eds) Stochastic biomathematical models. Springer, pp 3–35Google Scholar
  15. 15.
    Meng TC, Somani S, Dhar P (2004) Modeling and simulation of biological systems with stochasticity. Silico Biol 4:293–309Google Scholar
  16. 16.
    Rangamani P, Iyengar R (2008) Modelling cellular signalling systems. Essays Biochem 45:83–94CrossRefGoogle Scholar
  17. 17.
    Resat H, Costa MN, Shankaran H (2011) Spatial aspects in biological system simulations. Method Enzymol Elsevier 487:485–511CrossRefGoogle Scholar
  18. 18.
    Elias J, Jarray A, Salazar J, Karmouch A, Mehaoua A (2013) A reliable design of wireless body area networks. In: IEEE global communications conference, pp 2742–2748Google Scholar
  19. 19.
    Aguirre E et al (2016) Design and performance analysis of wireless body area networks in complex indoor e-Health hospital environments for patient remote monitoring. Int J Distrib Sens Netw 12(9):1–17CrossRefGoogle Scholar
  20. 20.
    Fatima M, Kiani AK, Baig A (2013) Medical body area network, architectural design and challenges: a survey. In: Shaikh FK, Chowdhry BS, Ammari HM, Uqaili MA, Shah A (eds) Wireless sensor networks for developing countries. Springer, pp 60–72Google Scholar
  21. 21.
    Yonzon CR, Stuart DA, Zhang X, McFarland AD, Haynes CL, Van Duyne RP (2005) Towards advanced chemical and biological nanosensors—an overview. Talanta 67:438–448CrossRefGoogle Scholar
  22. 22.
    Felicetti L, Femminella M, Reali G, Liò P (2014) A molecular communication system in blood vessels for tumor detection. In: Proceedings of the first annual international conference on nanoscale computing and communication, p 21Google Scholar
  23. 23.
    Nakano T, Kobayashi S, Suda T, Okaie Y, Hiraoka Y, Haraguchi T (2014) Externally controllable molecular communication. IEEE J Sel Areas Commun 32:2417–2431CrossRefGoogle Scholar
  24. 24.
    Chude-Okonkwo UAK, Malekian R, Maharaj BT (2016) Biologically inspired bio-cyber interface architecture and model for internet of bio-nanothings applications. IEEE Trans Commun 64:3444–3455CrossRefGoogle Scholar
  25. 25.
    Zhang X, Sun C, Fang N (2004) Manufacturing at nanoscale: top-down, bottom-up and system engineering. J Nanopart Res 6:125–130CrossRefGoogle Scholar
  26. 26.
    Akyildiz IF, Brunetti F, Blázquez C (2008) Nanonetworks: a new communication paradigm. Comput Netw 52:2260–2279CrossRefGoogle Scholar
  27. 27.
    Meyer RA, Meyer RS, Green JJ (2015) An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles. J Biomed Mater Res Part A 103:2747–2757CrossRefGoogle Scholar
  28. 28.
    Gong G et al (2011) Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting. Nanotechnology 22(9):1–9Google Scholar
  29. 29.
    Chu KS et al (2014) Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. Nano Lett 14:1472–1476CrossRefGoogle Scholar
  30. 30.
    Chi NT, Triet NM, Chien DM (2009) Preparation of drug nanoparticles by emulsion evaporation method. J Phys Conf Ser 187(1):1–5Google Scholar
  31. 31.
    Shah N, Sharma OP, Mehta T, Amin A (2016) Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies. Drug Dev Ind Pharm 42:825–835CrossRefGoogle Scholar
  32. 32.
    Delalat B et al (2015) Targeted drug delivery using genetically engineered diatom biosilica. Nat Commun 6(8791):1–11Google Scholar
  33. 33.
    Robertson D, Williams GH (2009) Clinical and translational science: principles of human research. Academic Press, United KingdomCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Uche Chude-Okonkwo
    • 1
  • Reza Malekian
    • 1
    Email author
  • B. T. Maharaj
    • 1
  1. 1.Department of Electrical, Electronic and Computer EngineeringUniversity of PretoriaHatfield, PretoriaSouth Africa

Personalised recommendations